The purpose of this review is to discuss the most recent evidence on the treatment innovations and future prospective in the management of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs).
Novel Therapies for ANCA-associated Vasculitis
Monti, Sara;Brandolino, Fabio;Milanesi, Alessandra;Xoxi, Blerina;Delvino, Paolo;Montecucco, Carlomaurizio
2021-01-01
Abstract
The purpose of this review is to discuss the most recent evidence on the treatment innovations and future prospective in the management of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
